Free Trial

EGB/Gilt: Fresh Vaccine Woes Trigger Core EGB Buying

BOND SUMMARY

European sovereign bonds traded weaker this morning before news that the US is calling for a pause on the Johnson & Johnson vaccine due to clotting fears triggered a leg higher for core EGBs.

  • Gilts now trade above yesterday's close with the curve a touch flatter.
  • The bund curve has similarly bull flattened with the 2s30s spread 1bp narrower on the day.
  • OAT yields are 1bp lower at the longer end.
  • The UK economy returned to positive growth in February, despite the national lockdown. The industrial sector has fared particularly well with output beating expectations.
  • Supply this morning came from the UK (Gilt , GBP1bn), Germany (Linker, EUR0.387bn allotted), Italy (BTPs, EUR7.75bn), Spain (Letras, EUR6.752bn), Belgium (TCs, EUR2.0bn), Finland (RFTBs, EUR2.0bn), the ESM (Bills, EUR.1bn). Syndications today include: Spain (15-year bond) Austria (dual tranche for 4-/50-year issues) and the Netherlands (0% Jan-38 DSL).

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.